Drugs Made In America Acquisition Corp (NASDAQ:DMAA) currently has a daily average trading volume of 212.73K but it saw 1071724 shares traded in last market. With a market cap of 233.98M USD, the company’s current market price of $10.06 came rising about 0.20 while comparing to the previous closing price of $10.04. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.27 and as low as $9.95. In the recent trading on the day, stock has struck highest price mark of $10.04 while lowest mark touched by it was $10.06.
Taking a look at 20-day trading activity of Drugs Made In America Acquisition Corp (DMAA) gives us an average price of $10.04, while its current price level is -2.04% below from 52-week high level whereas it is 1.11% above from lowest level seen by the stock during that period. A closer look into the stock’s movement over the week reveals that its volatility is standing at 0.12% during that period while stretching the period over a month that increases to 0.33%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.89 which implies that the stock is in neutral territory.
Over the week, DMAA’s stock price is moving 0.30% up while it is 0.20% when we observe its performance for the past one month. Year-to-date it is 1.00% up and over the past year.
The company is expected to be releasing its next quarterly report in May, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Drugs Made In America Acquisition Corp’s total number of outstanding shares is 33.52M with 26.77% of that held by the insiders while 0.15% of its common stock has been owned by the institutions.
